Plunkett Research Online: Audentes Therapeutics Inc

AUDENTES THERAPEUTICS INC (BOLD) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Audentes Therapeutics, Inc. is a biotechnology company committed to the development and commercialization of innovative gene therapy treatments for people with serious rare diseases. The firm currently has four programs in development: AT132 for the treatment of X-Linked Myotubular Myopathy, which .....


AUDENTES THERAPEUTICS INC

Ticker: BOLD
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 415-818-1001
Fax:
Address: 600 California St., 17/Fl
San Francisco, CA 94108 United States

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

Matthew PattersonCEO/Chairman of the Board/Co-Founder/Director
Thomas SolowayCFO/Chief Accounting Officer/Executive VP
See More
Audentes Therapeutics, Inc. is a biotechnology company committed to the development and commercialization of innovative gene therapy treatments for people with serious rare diseases. The firm currently has four programs in development: AT132 for the treatment of X-Linked Myotubular Myopathy, which .....See More See More

$USD, In whole numbers 2018201720162015201420132012
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture